Work

In Vitro Activity of Ceftazidime-Avibactam against Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Isolates

Year: 2018

Type: article

Abstract: Carbapenem-resistant and hypervirulent Klebsiella pneumoniae (CR-hvKp) strains have emerged while antimicrobial treatment options remain limited. Herein, we tested the in vitro activity of ceftazidime-avibactam and other comparator antibiotics against 65 CR-hvKp isolates.

Source: Antimicrobial Agents and Chemotherapy

DOI: 10.1128/aac.01031-18

Authors: Fangyou Yu, Jingnan Lv, Siqiang Niu, Hong Du, Yi-Wei Tang, Robert A. Bonomo, Barry N. Kreiswirth, Liang Chen

Institutions: Tongji University, First Affiliated Hospital of Wenzhou Medical University, Shanghai Pulmonary Hospital, The Affiliated Yongchuan Hospital of Chongqing Medical University, Second Affiliated Hospital of Soochow University, Memorial Sloan Kettering Cancer Center, Cornell University, Weill Cornell Medicine, Louis Stokes Cleveland VA Medical Center, Case Western Reserve University, Rutgers, The State University of New Jersey, Rutgers New Jersey Medical School

Language: English

Topic: Antibiotic Resistance in Bacteria

Subfield: Molecular Medicine

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Veterans Affairs, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases

Awards: G1003374595, Genomic variation in epidemic carbapenem-resistant K.pneumoniae, G1143233013, G3004358298, The molecular basis of the carbapenem resistance epidemic, G4070144744, G636376783, G797312326, Cancer Center Support Grant, Understanding B-Lactam Resistance in Acinetobacter baumannii

OpenAlex ID: W2806962419

FWCI: 1.002

Cites: 16

Cited by: 32

Related to: 10